A'Hern R - Search Results

1

Characterisation of TP53 abnormalities in chronic lymphocytic leukaemia.

Thornton PD, Gruszka-Westwood AM, Hamoudi RA, Atkinson S, Kaczmarek P, Morilla RM, Hilditch BL, A'Hern R, Matutes E, Catovsky D. Thornton PD, et al. Hematol J. 2004;5(1):47-54. doi: 10.1038/sj.thj.6200325. Hematol J. 2004. PMID: 14745430

2

CD38 expression as a prognostic indicator in chronic lymphocytic leukaemia.

Thornton PD, Fernandez C, Giustolisi GM, Morilla R, Atkinson S, A'Hern RP, Matutes E, Catovsky D. Thornton PD, et al. Hematol J. 2004;5(2):145-51. doi: 10.1038/sj.thj.6200360. Hematol J. 2004. PMID: 15048065 Clinical Trial.

3

Zeta-chain associated protein 70 and CD38 combined predict the time to first treatment in patients with chronic lymphocytic leukemia.

Del Giudice I, Morilla A, Osuji N, Matutes E, Morilla R, Burford A, Maravelaki S, Owusu-Ankomah K, Swansbury J, A'Hern R, Brito-Babapulle V, Catovsky D. Del Giudice I, et al. Cancer. 2005 Nov 15;104(10):2124-32. doi: 10.1002/cncr.21437. Cancer. 2005. PMID: 16211545 Free article.

4

The diagnostic value of CD123 in B-cell disorders with hairy or villous lymphocytes.

Del Giudice I, Matutes E, Morilla R, Morilla A, Owusu-Ankomah K, Rafiq F, A'Hern R, Delgado J, Bazerbashi MB, Catovsky D. Del Giudice I, et al. Haematologica. 2004 Mar;89(3):303-8. Haematologica. 2004. PMID: 15020268 Clinical Trial.

5

Improvement of the chronic lymphocytic leukemia scoring system with the monoclonal antibody SN8 (CD79b).

Moreau EJ, Matutes E, A'Hern RP, Morilla AM, Morilla RM, Owusu-Ankomah KA, Seon BK, Catovsky D. Moreau EJ, et al. Am J Clin Pathol. 1997 Oct;108(4):378-82. doi: 10.1093/ajcp/108.4.378. Am J Clin Pathol. 1997. PMID: 9322589 Clinical Trial.

6

The leukemic presentation of mantle-cell lymphoma: disease features and prognostic factors in 58 patients.

Matutes E, Parry-Jones N, Brito-Babapulle V, Wotherspoon A, Morilla R, Atkinson S, Elnenaei MO, Jain P, Giustolisi GM, A'Hern RP, Catovsky D. Matutes E, et al. Leuk Lymphoma. 2004 Oct;45(10):2007-15. doi: 10.1080/10428190410001723331. Leuk Lymphoma. 2004. PMID: 15370245

7

Second malignancy in hairy cell leukaemia: no evidence of increased incidence after treatment with interferon alpha.

Pawson R, A'Hern R, Catovsky D. Pawson R, et al. Leuk Lymphoma. 1996 Jun;22(1-2):103-6. doi: 10.3109/10428199609051735. Leuk Lymphoma. 1996. PMID: 8724535 Review.

8

No germline mutations in CDKN2A (p16) in patients with squamous cell cancer of the head and neck and second primary tumours.

Jefferies S, Edwards SM, Hamoudi RA, A'Hern R, Foulkes W, Goldgar D, Eeles R; MPT Collaborators. Jefferies S, et al. Br J Cancer. 2001 Nov 2;85(9):1383-6. doi: 10.1054/bjoc.2001.2068. Br J Cancer. 2001. PMID: 11720478 Free PMC article.

9

Extreme chromosomal instability forecasts improved outcome in ER-negative breast cancer: a prospective validation cohort study from the TACT trial.

Jamal-Hanjani M, A'Hern R, Birkbak NJ, Gorman P, Grönroos E, Ngang S, Nicola P, Rahman L, Thanopoulou E, Kelly G, Ellis P, Barrett-Lee P, Johnston SR, Bliss J, Roylance R, Swanton C. Jamal-Hanjani M, et al. Ann Oncol. 2015 Jul;26(7):1340-6. doi: 10.1093/annonc/mdv178. Epub 2015 May 23. Ann Oncol. 2015. PMID: 26003169 Free article. Clinical Trial.

10

Breast cancer molecular profiling with single sample predictors: a retrospective analysis.

Weigelt B, Mackay A, A'hern R, Natrajan R, Tan DS, Dowsett M, Ashworth A, Reis-Filho JS. Weigelt B, et al. Lancet Oncol. 2010 Apr;11(4):339-49. doi: 10.1016/S1470-2045(10)70008-5. Epub 2010 Feb 22. Lancet Oncol. 2010. PMID: 20181526 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

283 results

Search Page

Filters